Diabetes Management Guidelines
American Diabetes Association (ADA) 2013 Guidelines
Updated recommendations are available. Click here.
Source: American Diabetes Association. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36(suppl 1):S11-S66.
Jump to a section or click the arrow at the bottom right of each section
Insulin Therapy :: Self-Monitoring and Continuous Monitoring of Blood Glucose Updated recommendations are available. Click here.
Self-Monitoring of Blood Glucose (SMBG)
- Encourage for patients receiving multiple-dose insulin or insulin pump therapy
- At least prior to meals and snacks
- Occasionally postprandially
- At bedtime
- Prior to exercise
- When low blood glucose is suspected
- After treating low blood glucose until normoglycemic
- Prior to critical tasks (such as driving)
- Results may be useful for guiding treatment decisions and/or patient self-management for those using less frequent insulin injections or noninsulin therapies
- Provide ongoing instruction and regular evaluation of SMBG technique and results; data from SMBG may be used to adjust therapy
Continuous Glucose Monitoring (CGM)
- In selected adults (aged ≥25 yrs) with type 1 diabetes along with intensive insulin treatment regimens can be useful for A1C lowering
- May be useful among children, teens, and younger adults, although evidence for A1C lowering is less strong in these populations
- Success is related to adherence to ongoing use of the device
- May be a useful supplement to SMBG among patients with hypoglycemia unawareness and/or frequent hypoglycemic episodes
ADA Guidelines: Glucose Monitoring (1 of 2)
ADA Guidelines: Glucose Monitoring (2 of 2)
SMBG=self-monitoring of blood glucose
This content was created by KnowledgePoint360 Group, LLC, and was not associated with funding via an educational grant or a promotional/commercial interest.